🔥🐔 BizChicken 🐔🔥
Companies Similar to Galera Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Galera Therapeutics, Inc.
avasopasem manganese (GC4419)
Galera Therapeutics, Inc. is a clinical stage biopharmaceutical company focusing on developing and commercializing therapeutics aimed at transforming radiotherapy in cancer. Their lead product candidate, avasopasem manganese, has completed a Phase III clinical trial targeting oral mucositis in head and neck cancer patients.
Symbol: GRTX
Recent Price: $0.03
Industry: Biotechnology
CEO: Dr. J. Mel Sorensen M.D.
Sector: Healthcare
Employees: 7
Address: 2 West Liberty Boulevard, Malvern, PA 19355
Phone: 610 725 1500
Leadership
- J. Mel Sorensen, MD, President and Chief Executive Officer
- Lawrence Alleva, Chair of the Board of Directors
- Emmett Cunningham, MD, PhD, Board Member
- Kevin Lokay, MS, Board Member
- Michael Powell, PhD, Chair of the Nominating and Corporate Governance Committee
- Linda West, Chair of the Compensation Committee
Last updated: 2024-12-31
Mersana Therapeutics, Inc.
XMT-1592
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing antibody drug conjugates (ADC) for treating cancer patients with unmet needs. It specializes in ADC products like XMT-1592 and has strategic partnerships for the advancement of its innovative therapeutics.
Vision/Values | About | Directors | About | About | About | About | Contact | Contact | About | Careers | About | Culture | Benefits | Careers | Careers | Careers | Jobs | Jobs | Management | Careers | About | About | About | About
Symbol: MRSN
Recent Price: $1.42
Industry: Biotechnology
CEO: Dr. Martin H. Huber M.D.
Sector: Healthcare
Employees: 123
Address: 840 Memorial Drive, Cambridge, MA 02139
Phone: 617 498 0020
Leadership
- David Mott, Chairman of the Board
- Lawrence Alleva, Retired Partner, PriceWaterhouseCoopers
- Willard H. Dere, MD, Professor Emeritus of Internal Medicine, University of Utah
- Allene M. Diaz, Independent Commercial Strategy and Portfolio Management Consultant, AMD Consulting
- Andrew Hack MD, PhD, Managing Director, Bain Capital Life Sciences
- Kristen M. Hege, MD, Retired Senior Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy, Bristol Myers Squibb Company
- Anna Protopapas, Chair of the board of directors of Nuvalent
- Martin Huber, MD, President and Chief Executive Officer
Last updated: 2024-12-31
Travere Therapeutics, Inc.
Chenodal, Cholbam, Thiola, Sparsentan, TVT-058
Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.
About | Leadership | About | About | About | Contact | Contact | Careers | Careers | About | News | About | About | About | About | About | About | News | Events | About | About | ESG | About | Jobs | Jobs | Careers | About | About | About | About
Symbol: TVTX
Recent Price: $17.32
Industry: Biotechnology
CEO: Dr. Eric M. Dube Ph.D.
Sector: Healthcare
Employees: 380
Address: 3611 Valley Centre Drive, San Diego, CA 92130
Phone: 888 969 7879
Leadership
- Eric Dube, Ph.D., President & Chief Executive Officer
- Chris Cline, CFA, Chief Financial Officer
- Angela Giannantonio, Senior Vice President, Human Resources
- Peter Heerma, Chief Commercial Officer
- Jula Inrig, M.D., Chief Medical Officer
- Casey Logan, Chief Business Officer
- Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
- William Rote, Ph.D., Senior Vice President, Research & Development
- Charlotte Smith, Senior Vice President, Public Affairs
- Gary A. Lyons, Chairman
- Roy D. Baynes, M.D., Ph.D.,
- Suzanne L. Bruhn, Ph.D.,
- Tim Coughlin, CPA,
- Jeffrey A. Meckler,
- John A. Orwin,
- Sandra E. Poole,
- Ron Squarer,
- Ruth Williams-Brinkley, FACHE,
Last updated: 2024-12-31
Aileron Therapeutics, Inc.
ALRN-6924
Aileron Therapeutics, Inc. is a clinical stage oncology company developing ALRN-6924 for various cancer treatments, with multiple clinical trials in progress.
Symbol: ALRN
Recent Price: $2.32
Industry: Biotechnology
CEO: Dr. James Brian Windsor Ph.D.
Sector: Healthcare
Employees: 15
Address: 285 Summer Street, Boston, MA 02210
Phone: 617 995 0900
Last updated: 2024-12-31
Arvinas, Inc.
Bavdegalutamide, ARV-471, ARV-766
Arvinas, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company is based in New Haven, Connecticut and collaborates with organizations like Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG.
About | Leadership | Contact | Culture | Culture | Culture | About | News | Events | ESG | About | About | About | About | About | About | About | About | About | About | About | About | Events | ESG | About | About | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | Careers | About | About | About | About | News | About | About | Contact | About | About
Symbol: ARVN
Recent Price: $19.00
Industry: Biotechnology
CEO: Dr. John G. Houston Ph.D.
Sector: Healthcare
Employees: 445
Address: 5 Science Park, New Haven, CT 06511
Phone: 203 535 1456
Leadership
- John G. Houston, Ph.D., Chairperson, Chief Executive Officer, and President
- Noah Berkowitz, M.D., Ph.D., Chief Medical Officer
- Angela M. Cacace, Ph.D., Chief Scientific Officer
- Jared Freedberg, J.D., General Counsel and Corporate Secretary
- Paul McInulty, Senior Vice President, Regulatory Affairs
- John Northcott, Chief Commercial Officer
- Kelly Page, Senior Vice President, Global Head of Oncology Strategy and Program Leadership
- Andrew Saik, Chief Financial Officer
- Lisa Sinclair, Senior Vice President, Corporate Operations
- Ian Taylor, Ph.D., President, R&D
- Randy Teel, Ph.D., Chief Business Officer
- Steve Weiss, Senior Vice President, Chief Human Resources Officer
Last updated: 2024-12-31
Avalo Therapeutics, Inc.
AVTX-002, AVTX-007, AVTX-801
Avalo Therapeutics, Inc. is a clinical-stage precision medicine company focused on discovering, developing, and commercializing targeted therapeutics for patients with unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.
Symbol: AVTX
Recent Price: $7.80
Industry: Biotechnology
CEO: Dr. Garry A. Neil M.D.
Sector: Healthcare
Employees: 19
Address: 540 Gaither Road, Rockville, MD 20850
Phone: 410 522 8707
Leadership
- Garry A. Neil, MD, Chairman of the Board and Chief Executive Officer
- Mittie Doyle, MD, FACR, Chief Medical Officer
- Chris Sullivan, Chief Financial Officer
- Paul Varki, Chief Legal Officer
- Lisa Hegg PhD, Senior Vice President, Program Management and Corporate Infrastructure and Clinical Operations
- Colleen Matkowski, Senior Vice President, Global Regulatory Affairs and Quality Assurance
- Dino C. Miano, PhD, Senior Vice President, CMC and Technical Operations
- June Almenoff, MD, PhD, President and Chief Medical Officer
- Mitchell Chan, Chief Financial Officer
- Jonathan Goldman, MD, CEO
- Aaron Kantoff, Managing Partner
- Gilla Kaplan, PhD, Independent Director
- Samantha Truex, CEO
Last updated: 2024-12-31
Galectin Therapeutics Inc.
belapectin (GR-MD-02)
Galectin Therapeutics Inc. engages in research and development of therapies for fibrotic, cancer, and other diseases, with a focus on developing galectin-3 inhibitors like belapectin.
Symbol: GALT
Recent Price: $1.10
Industry: Biotechnology
CEO: Mr. Joel Lewis
Sector: Healthcare
Employees: 14
Address: 4960 Peachtree Industrial Boulevard, Norcross, GA 30071
Phone: 678 620 3186
Last updated: 2024-12-31
Geron Corporation
Imetelstat
Geron Corporation is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapeutics for myeloid hematologic malignancies, notably through their telomerase inhibitor, imetelstat, which is in Phase 3 clinical trials.
Symbol: GERN
Recent Price: $3.40
Industry: Biotechnology
CEO: Dr. John A. Scarlett M.D.
Sector: Healthcare
Employees: 141
Address: 919 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 473 7700
Leadership
- John A. Scarlett, M.D., Chairman of the Board, President and Chief Executive Officer
- Melissa A. Kelly Behrs, Executive Vice President, Business Operations and Chief Alliance Officer
- Faye Feller, M.D., Executive Vice President, Chief Medical Officer
- Andrew J. Grethlein, Ph.D., Executive Vice President, Chief Operating Officer
- Edward Koval, Executive Vice President and Chief Business Officer
- Shannon T. Odam, Senior Vice President, Chief People Officer
- Michelle Robertson, Executive Vice President, Chief Financial Officer and Treasurer
- Scott A. Samuels, Esq., Executive Vice President, Chief Legal Officer and Secretary
- Jim Ziegler, Executive Vice President, Chief Commercial Officer
- Gaurav Aggarwal, M.D., Compensation Committee, Strategic Committee (Chair)
- Dawn C. Bir, Nominating and Corporate Governance Committee (Chair), Compensation Committee
- V. Bryan Lawlis, Ph.D., Audit Committee, Nominating and Corporate Governance Committee
- John F. McDonald, Audit Committee, Strategic Committee
- Susan M. Molineaux, Ph.D., Compensation Committee (Chair), Nominating and Corporate Governance Committee
- Elizabeth G. O’Farrell, Lead Director, Audit Committee (Chair), Strategic Committee
- Robert J. Spiegel, M.D., FACP, Compensation Committee, Nominating and Corporate Governance Committee
Last updated: 2024-12-31
Jasper Therapeutics, Inc.
JSP191
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutic agents for hematopoietic stem cell transplantation and gene therapies. Its lead product candidate JSP191 is in clinical development for clearing hematopoietic stem cells from bone marrow in patients prior to transplantation.
Symbol: JSPR
Recent Price: $20.95
Industry: Biotechnology
CEO: Mr. Ronald A. Martell
Sector: Healthcare
Employees: 45
Address: 2200 Bridge Pkwy, Redwood City, CA 94065
Phone: 650 549 1400
Last updated: 2024-12-31
Keros Therapeutics, Inc.
KER-050
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for hematological and musculoskeletal disorders. Their lead product candidate, KER-050, targets cytopenias, including anemia and thrombocytopenia.
About | Management | Directors | Contact | About | Contact | Careers | Benefits | Careers | About | Benefits | About | Careers | Jobs | Careers | Careers | Careers
Symbol: KROS
Recent Price: $15.64
Industry: Biotechnology
CEO: Dr. Jasbir S. Seehra Ph.D.
Sector: Healthcare
Employees: 149
Address: 99 Hayden Avenue, Lexington, MA 02421
Phone: 617 314 6297
Leadership
- Jasbir Seehra, Ph.D., Board Member
- Keith Regnante, M.B.A., Chief Financial Officer
- Christopher Rovaldi, President, Chief Operating Officer
- Esther Cho, J.D., Senior Vice President, General Counsel
- John Oram, M.B.A., Senior Vice President, Program and Portfolio Management
- Robin Wagner, Senior Vice President, Human Resources
- Carl L. Gordon, Ph.D., C.F.A., Board Member
- Jean-Jacques Bienaimé, M.B.A., Lead Independent Director
- Nima Farzan, M.B.A., Board Member
- Mary Ann Gray, Ph.D., Board Member
- Tomer Kariv, J.D., Board Member
- Julius Knowles, M.B.A., Board Member
- Ran Nussbaum, Board Member
- Alpna Seth, Ph.D., Board Member
Last updated: 2024-12-31
Kintara Therapeutics, Inc.
VAL-083, REM-001
Kintara Therapeutics is a clinical stage drug development company focused on developing and commercializing anti-cancer therapies for drug-resistant solid tumors.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About
Symbol: KTRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Sector: Healthcare
Employees: 1
Address: 12707 High Bluff Drive, San Diego, CA 92130
Phone: 858 350 4364
Leadership
- Robert E. Hoffman, President, CEO, CFO and Chairman of the Board
- Greg A. Johnson, (Acting) Head of Operations
- Laura Johnson, Director
- Tamara A. Favorito, Director
- Robert J. Toth, Jr., M.B.A., Director
Last updated: 2024-12-31
SELLAS Life Sciences Group, Inc.
galinpepimut-S (GPS)
SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focusing on the development of novel cancer immunotherapies in the United States. Their lead product candidate, galinpepimut-S (GPS), is in Phase III clinical trials for acute myeloid leukemia and Phase 1/2 for ovarian cancer.
Symbol: SLS
Recent Price: $0.99
Industry: Biotechnology
CEO: Dr. Angelos M. Stergiou M.D., ScD h.c.
Sector: Healthcare
Employees: 16
Address: Times Square Tower, New York, NY 10036
Phone: 646 200 5278
Last updated: 2024-12-31
Protara Therapeutics, Inc.
N/A
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
No tags available.
Symbol: TARA
Recent Price: $5.28
Industry: Biotechnology
CEO: Mr. Jesse Shefferman
Sector: Healthcare
Employees: 26
Address: 345 Park Avenue South, New York, NY 10010
Phone: 646 844 0337
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Vor Biopharma Inc.
VOR33
Vor Biopharma, Inc. is a clinical-stage company focused on developing engineered hematopoietic stem cell (e HSC) therapies for cancer patients, with a leading product, VOR33, in phase 1/2 trials for AML and other hematological malignancies.
About | Vision/Values | About | Leadership | Directors | About | About | Contact | Contact | News | Careers | About | About | About
Symbol: VOR
Recent Price: $1.19
Industry: Biotechnology
CEO: Dr. Robert Ang M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 168
Address: 100 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 655 6580
Leadership
- Robert Ang, MBBS, MBA, President and Chief Executive Officer
- Eyal Attar, MD, Chief Medical Officer
- Tirtha Chakraborty, PhD, Chief Scientific Officer
- Han Choi, MD, LLM, Chief Financial Officer
- John King, MBA, Chief Commercial Officer and Head of Business Development
- Tania Philipp, Chief People Officer
- David Phillips, MBA, Senior Vice President, Head of Quality
- Samir Vattompadam, MS, Senior Vice President, Portfolio Strategy and Program Management
- Daniella Beckman, Board of Directors
- David Lubner, Board of Directors
- Bill Lundberg, MD, Board of Directors
- Fouad Namouni, MD, Board Of Directors
- Matthew R. Patterson, Chairman, Board of Directors
- Josh Resnick, MD, Board of Directors
Last updated: 2024-12-31
Verastem, Inc.
VS-6766
Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for cancer treatment, with products such as VS-6766 and trials like RAMP 201 and 202 targeting various cancer types.
Symbol: VSTM
Recent Price: $3.67
Industry: Biotechnology
CEO: Mr. Daniel W. Paterson
Sector: Healthcare
Employees: 73
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 781 292 4200
Last updated: 2024-12-31
X4 Pharmaceuticals, Inc.
mavorixafor
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.
Symbol: XFOR
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Paula Ragan Ph.D.
Sector: Healthcare
Employees: 127
Address: 61 North Beacon Street, Boston, MA 02134
Phone: 857 529 8300
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
Monte Rosa Therapeutics, Inc.
oral molecular glue degrader for GSPT1
Monte Rosa Therapeutics, Inc. is a biopharmaceutical company focused on developing novel small molecule precision medicines. These medicines utilize the body's natural mechanisms to selectively degrade proteins relevant in therapeutic treatments, targeting various cancers, inflammatory, neurodegenerative, autoimmune diseases, and hemoglobinopathies.
About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About
Symbol: GLUE
Recent Price: $7.02
Industry: Biotechnology
CEO: Dr. Markus Warmuth M.D.
Sector: Healthcare
Employees: 129
Address: 645 Summer Street, Boston, MA 02210
Phone: 617 949 2643
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31